Mario Campero Selected Research

Nemaline myopathy 1

1/2022

Novel autosomal dominant TPM3 mutation causes a combined congenital fibre type disproportion-cap disease histological pattern.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mario Campero Research Topics

Disease

1	Nemaline myopathy 1 01/2022
1	Cap Myopathy 01/2022
1	Apnea 01/2022
1	Muscular Diseases (Myopathy) 01/2022
1	Congenital Structural Myopathies (Centronuclear Myopathy) 01/2022
1	Polyneuropathies (Polyneuropathy) 01/2020
1	Diabetes Mellitus 01/2020
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2020
1	Foot Ulcer 01/2020
1	Inflammation (Inflammations) 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Ataxia (Dyssynergia) 05/2017
1	Cerebellar Diseases (Cerebellar Syndrome) 05/2017
1	Paraneoplastic Cerebellar Degeneration 05/2017
1	Adenocarcinoma 05/2017
1	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 01/2017
1	Neuromuscular Junction Diseases 01/2017
1	Dysferlinopathy 01/2016
1	Non-Langerhans-Cell Histiocytosis (Histiocytosis, Non Langerhans Cell) 01/2016
1	Erdheim-Chester Disease 01/2016
1	Hyperalgesia 06/2004

Drug/Important Bio-Agent (IBA)

1	TropomyosinIBA 01/2022
1	NAD (NADH)IBA 01/2020
1	Conditioned Culture MediaIBA 01/2020
1	Anti-Idiotypic AntibodiesIBA 05/2017
1	anti-Yo autoantibodiesIBA 05/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2016
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2016
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2016
1	Capsaicin (Zostrix)FDA Link 06/2004

Therapy/Procedure

1	Noninvasive Ventilation 01/2022
1	Therapeutics 01/2020
1	Surgical Amputation (Amputations) 01/2020
1	Intradermal Injections 06/2004